PE20020214A1 - Compuestos esteroides con anillo e adicional que tienen actividad anticonceptiva y antiosteoporosica - Google Patents
Compuestos esteroides con anillo e adicional que tienen actividad anticonceptiva y antiosteoporosicaInfo
- Publication number
- PE20020214A1 PE20020214A1 PE2001000401A PE2001000401A PE20020214A1 PE 20020214 A1 PE20020214 A1 PE 20020214A1 PE 2001000401 A PE2001000401 A PE 2001000401A PE 2001000401 A PE2001000401 A PE 2001000401A PE 20020214 A1 PE20020214 A1 PE 20020214A1
- Authority
- PE
- Peru
- Prior art keywords
- ring
- alkyl
- contraceptive
- activity
- additional
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A ESTEROIDES CON UN ANILLO E ADICIONAL DE FORMULA I DONDE R6 ES H, =CH2, CH3, CH2-CH3; R7 ES H, ALQUILO C1-C4, ALQUENILO C2-C5, ALQUINILO C2-C5 OPCIONALMENTE SUSTITUIDO CON HALOGENO; R11 ES H, ALQUILO C1-C4, ALQUENILO C2-C4, ALQUINILO C2-C4 ALQUILIDENO C1-C4, OPCIONALMENTE SUSTITUIDOS CON HALOGENO; E JUNTO A C16 Y C17 DEL ESTEROIDE FORMAN UN ANILLO DE 4 A 7 MIEMBROS, ESTANDO DICHO ANILLO EN CONFIGURACION CIS CON RESPECTO AL ESQUELETO DEL ESTEROIDE, OPCIONALMENTE CON UNO O DOS ENLACES ENDOCICLICOS. UN COMPUESTO PREFERIDO (7a,16b,17a,22S)-7-PROPIL-16,24-CICLO-19, 21-DINORCOLA-1,3,5(10)-TRIENO-3,17,22-TRIOL. LOS COMPUESTOS MODIFICAN LA ACTIVIDAD DE LOS RECEPTORES DE ESTROGENOS a, b Y PUEDEN SER UTILES PARA EL TRATAMIENTO DE MOLESTIAS MENOPAUSICAS, OSTEOPOROSIS, CONTROL DE TUMORES DEPENDIENTES DE ESTROGENOS, COMO ANTICONCEPTIVO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00201986 | 2000-06-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20020214A1 true PE20020214A1 (es) | 2002-03-13 |
Family
ID=8171601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2001000401A PE20020214A1 (es) | 2000-06-06 | 2001-05-03 | Compuestos esteroides con anillo e adicional que tienen actividad anticonceptiva y antiosteoporosica |
Country Status (27)
| Country | Link |
|---|---|
| US (3) | US7868193B2 (es) |
| EP (1) | EP1294739B1 (es) |
| JP (1) | JP5095902B2 (es) |
| KR (1) | KR100769865B1 (es) |
| CN (1) | CN1235908C (es) |
| AR (1) | AR028080A1 (es) |
| AT (1) | ATE293124T1 (es) |
| AU (2) | AU5838601A (es) |
| BR (1) | BR0111445A (es) |
| CA (1) | CA2410220C (es) |
| CZ (1) | CZ20024014A3 (es) |
| DE (1) | DE60110069T2 (es) |
| DK (1) | DK1294739T3 (es) |
| ES (1) | ES2240454T3 (es) |
| HK (1) | HK1052012A1 (es) |
| HU (1) | HUP0301190A3 (es) |
| IL (1) | IL152957A0 (es) |
| MX (1) | MXPA02012117A (es) |
| NO (1) | NO324247B1 (es) |
| PE (1) | PE20020214A1 (es) |
| PL (1) | PL203732B1 (es) |
| PT (1) | PT1294739E (es) |
| RU (1) | RU2255090C2 (es) |
| SK (1) | SK286852B6 (es) |
| TW (1) | TWI225068B (es) |
| WO (1) | WO2002000682A1 (es) |
| ZA (1) | ZA200209452B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8367648B2 (en) | 2009-06-10 | 2013-02-05 | Msd Oss B.V. | Substituted 16,17-annellated steroid compounds for use in womens healthcare |
| TW201109346A (en) * | 2009-06-10 | 2011-03-16 | Organon Nv | Substituted 16,17-annellated steroid compounds for use in women's healthcare |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3194821A (en) * | 1963-12-30 | 1965-07-13 | Abbott Lab | 17alpha-substituted 17beta-hydroxyestrenes |
| CA2200423C (en) | 1996-03-26 | 2006-12-19 | Sietse Mosselman | Novel estrogen receptor |
| IL123195A (en) * | 1997-02-21 | 2002-11-10 | Akzo Nobel Nv | Steroid compounds with anti-pregnancy activity and against bone thinning, preparation and pharmaceutical preparations containing them |
-
2001
- 2001-04-17 TW TW090109186A patent/TWI225068B/zh not_active IP Right Cessation
- 2001-05-01 SK SK1707-2002A patent/SK286852B6/sk not_active IP Right Cessation
- 2001-05-01 CA CA002410220A patent/CA2410220C/en not_active Expired - Fee Related
- 2001-05-01 US US10/297,706 patent/US7868193B2/en not_active Expired - Fee Related
- 2001-05-01 DK DK01931676T patent/DK1294739T3/da active
- 2001-05-01 ES ES01931676T patent/ES2240454T3/es not_active Expired - Lifetime
- 2001-05-01 DE DE60110069T patent/DE60110069T2/de not_active Expired - Lifetime
- 2001-05-01 RU RU2002135594/04A patent/RU2255090C2/ru not_active IP Right Cessation
- 2001-05-01 MX MXPA02012117A patent/MXPA02012117A/es active IP Right Grant
- 2001-05-01 AU AU5838601A patent/AU5838601A/xx active Pending
- 2001-05-01 KR KR1020027016657A patent/KR100769865B1/ko not_active IP Right Cessation
- 2001-05-01 AT AT01931676T patent/ATE293124T1/de active
- 2001-05-01 WO PCT/EP2001/004868 patent/WO2002000682A1/en active IP Right Grant
- 2001-05-01 HU HU0301190A patent/HUP0301190A3/hu unknown
- 2001-05-01 BR BR0111445-0A patent/BR0111445A/pt not_active IP Right Cessation
- 2001-05-01 AU AU2001258386A patent/AU2001258386B2/en not_active Ceased
- 2001-05-01 IL IL15295701A patent/IL152957A0/xx not_active IP Right Cessation
- 2001-05-01 EP EP01931676A patent/EP1294739B1/en not_active Expired - Lifetime
- 2001-05-01 JP JP2002505804A patent/JP5095902B2/ja not_active Expired - Fee Related
- 2001-05-01 CZ CZ20024014A patent/CZ20024014A3/cs unknown
- 2001-05-01 PL PL359238A patent/PL203732B1/pl not_active IP Right Cessation
- 2001-05-01 PT PT01931676T patent/PT1294739E/pt unknown
- 2001-05-01 CN CNB018107451A patent/CN1235908C/zh not_active Expired - Fee Related
- 2001-05-03 PE PE2001000401A patent/PE20020214A1/es not_active Application Discontinuation
- 2001-05-04 AR ARP010102107A patent/AR028080A1/es unknown
-
2002
- 2002-11-20 ZA ZA200209452A patent/ZA200209452B/en unknown
- 2002-12-02 NO NO20025793A patent/NO324247B1/no not_active IP Right Cessation
-
2003
- 2003-06-17 HK HK03104310A patent/HK1052012A1/xx not_active IP Right Cessation
-
2010
- 2010-06-15 US US12/816,058 patent/US20100249083A1/en not_active Abandoned
-
2011
- 2011-05-20 US US13/112,184 patent/US20110224183A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP055576A (es) | Uso de derivados de ciclotiocarbamato en el tratamiento de las condiciones relacionadas con hormonas | |
| ES2566960T3 (es) | Tratamiento de la insuficiencia cardíaca en los animales mamíferos no humanos con un antagonista de la aldosterona | |
| BR0109983A (pt) | Estratrienos substituìdos por 8.beta-hidrocarbila como estrogênios seletivamente eficientes | |
| CY1123239T1 (el) | Συνθεσεις και μεθοδοι για καταστολη ενδομητριωνυπερπλασιων | |
| EA200400337A1 (ru) | Применение модулятора рецепторов глюкокортикоидов и агониста рецепторов глюкокортикоидов при получении лекарственного средства | |
| ES2173956T3 (es) | Suelo estabilizante y mezclas agregadas y estructuras. | |
| BR112022020710A2 (pt) | Composições contraceptivas com efeitos adversos reduzidos | |
| AR034392A1 (es) | Compuestos derivados de 3, 16-dihidroxi-estra-1,3,5(10)-trieno, empleo de los mismos y de partes estructurales de los mismos y composiciones farmaceuticas que los contienen | |
| PE20020214A1 (es) | Compuestos esteroides con anillo e adicional que tienen actividad anticonceptiva y antiosteoporosica | |
| BRPI0416208A (pt) | moduladores de receptores de androgênio | |
| HN2002000170A (es) | Metodo para producir clinker de cemento utilizando coque de alto contenido de azufre | |
| Dube et al. | Estradiol and progesterone receptors in dog prostate cytosol | |
| PA8633601A1 (es) | Profarmacos de esteroides con accion androgenica | |
| DE602004014640D1 (de) | Tricyclische modulatoren von nuklearen steroidhormonrezeptoren | |
| PE20070182A1 (es) | Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona | |
| PA8633801A1 (es) | Derivados de sulfamoilbenzoato y sulfamoilaminobenzoato de estriol, y derivados de sulfamoilbenzoato y sulfamoilaminobenzoato de estetrol | |
| CU23414B7 (es) | Estratrienos 9-alfa-sustituidos como estrógenos de eficacia selectiva | |
| BR0013769A (pt) | Esteróides estrogênicos não aromáticos, composição farmacêutica, e, uso de um composto esteróide | |
| PE20020472A1 (es) | Uso de un inhibidor del receptor de progesterona para inhibir la fijacion de factores de crecimiento en celulas tumorales | |
| Nutting et al. | Anabolic-androgenic activity of A-ring modified androstane derivatives. Part I: A comparison of parenteral activity | |
| UY26665A1 (es) | Estratrienos sustituidos como estrógenos selectivamente activos | |
| PE20010579A1 (es) | Mesoprogestinas (modulares de receptores de progesterona) como componentes de anticonceptivos femeninos | |
| PE20090825A1 (es) | Estratrienos 8-beta-sustituidos como estrogenos de accion selectiva | |
| CO5200772A1 (es) | Mesoprogestinas (moduladores de receptores de progesterona) para el trataiento y la prevencion de transtornos ginecolo- gicos benignos hormona-dependientes | |
| AR039227A1 (es) | Terapia de reemplazo hormonal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |